TYROSINE KINASE INHIBITORS AND INTERFERON
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was considered as a breakthrough in the therapy of this disease; INF administered alone or in combination with aracytine was the standard choice for treatment for Chronic Myeloid Leukemia (CML) patients unfi...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
PAGEPress Publications
2014-01-01
|
| Serie: | Mediterranean Journal of Hematology and Infectious Diseases |
| Soggetti: | |
| Accesso online: | http://www.mjhid.org/index.php/mjhid/article/view/1359 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|